MAPT and Alzheimer disease: We utilized this method and purified NDEs from plasma samples of individuals with DS at different ages, extending from childhood to older adults [20], and showed that NDEs from children with DS already contained AD-related p-Tau species at an early stage in life, compared to typically developing children.